Technology News and Research

RSS

Biocartis announces the successful closing of Series A equity financing round

Biocartis SA, a diagnostics company focused on fast and low-cost, integrated molecular and immunodiagnostics based on its proprietary micro-technology platform, today announced the successful closing of a Series A equity financing round. The Company raised EUR 10 million (~ USD 14.9 million) from a syndicate of leading life science investors.

From Biocartis 15 Oct 2009

BioMedReports.Com releases an exclusive interview with spokesman for Biomagnetics Diagnostics

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has released an exclusive interview with a spokesman for Biomagnetics Diagnostics Corp., the company behind a revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV and hepatitis field testing.

15 Oct 2009

Health Sciences South Carolina, Recombinant Data and Sun Microsystems to collaborate on an Integrated Platform for Research

Health Sciences South Carolina (HSSC), today announced that it has selected Recombinant Data Corp. and Sun Microsystems, Inc. to collaborate on the Health Sciences South Carolina Integrated Platform for Research (HS-SCIPR), an unprecedented statewide initiative for translational research and quality improvement.

15 Oct 2009

NexMed completes its post hoc analysis of NM100060

NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has completed its post hoc analysis of NM100060, the Company’s topically-applied treatment for onychomycosis, commonly known as nail fungus. Based on this analysis, NexMed seeks to pursue signing a partner for further development of the product.

15 Oct 2009

Futronic Technology's WBF Driver passes WHQL test

Futronic Technology Company Limited, a global provider of fingerprint recognition software and hardware products, announces that its Windows Biometric Framework (WBF) Driver for its USB fingerprint scanner has successfully passed WHQL test for both 32 bit and 64 bit Windows 7, a new PC operating system that will be released by Microsoft soon.

15 Oct 2009

MMR Information Systems, Unis-Tonghe Technology ink Memorandum of Understanding

MMR Information Systems, Inc. and Unis-Tonghe Technology (Zhengzhou) Co., Ltd., announced today that the companies have entered into a Memorandum of Understanding ("MOU") and plan to sign a Master Agreement by December 15, 2009.

15 Oct 2009

Windsor Place of Wilmington opens to welcome new residents

Windsor Place of Wilmington, a premier assisted living residence for seniors, announced today that it will welcome residents this month. Windsor Place has 87 distinctive luxury suites. A portion are designated for individuals with memory impairment due to Alzheimer’s disease and related disorders.

15 Oct 2009

NICoE to study how brain works after sustaining combat-related injury using Elekta Neuromag

Projected to open in mid 2010, the National Intrepid Center of Excellence (NICoE) is a facility dedicated to the study and care of military personnel and veterans suffering from traumatic brain injury (TBI) and psychological health issues. Using Elekta Neuromag®, an advanced magnetoencephalography (MEG) device, NICoE plans to shed light on how the brain works after sustaining combat-related injury.

From Elekta 15 Oct 2009

National Institutes of Health grants $12 million to WCDRC for obesity research

The Miriam Hospital's Weight Control and Diabetes Research Center (WCDRC) recently received six research grants from the National Institutes of Health - totaling more than $12 million in funding - that will support the work of researchers focused on the prevention and treatment of obesity.

15 Oct 2009

Envoy Therapeutics raises $8 million through private placement

Envoy Therapeutics, Inc., a newly formed drug discovery company, today announced the closing of its first financing, an $8 million private placement of the company’s Series A Preferred Stock. Led by 5AM Ventures, other investors participating in the financing included Takeda Research Investment and Roche Venture Fund.

15 Oct 2009

NIH grants Affymetrix $24.8M for genotyping project

Affymetrix, Inc. today announced that the Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) and the University of California at San Francisco (UCSF) have entered into an agreement with Affymetrix to support genome-wide analyses of DNA samples from 100,000 Kaiser Permanente members.

15 Oct 2009

CalRHIO's statewide HIE system implemented in Orange County

The first site in CalRHIO's statewide health information exchange (HIE) system is live in Orange County at Coastal Communities Hospital. As a result of collaboration between CalRHIO and the local HIE effort, the Orange County Partnership Regional Health Information Organization (OCPRHIO), 23 hospital emergency departments over the next five months will have secure electronic access to critical medical information.

15 Oct 2009

AbbeyMoor Medical's The Spanner temporary prostatic stent insertion procedure receives Category I CPT code

AbbeyMoor Medical Inc. announced today they have been granted a Category I CPT code by the American Medical Association (AMA) for The Spanner(TM) temporary prostatic stent insertion procedure. This important action, effective in January 2010, upgrades The Spanner from a Category III emerging technology procedure code to a Category I procedure code for established procedures.

15 Oct 2009

Hoag Memorial Hospital implements PCTS' Amelior EDTracker software

Patient Care Technology Systems (PCTS), a subsidiary of Consulier Engineering, Inc., today announced that Hoag Memorial Hospital Presbyterian has implemented the company's Amelior EDTracker® solution to automatically track patients in its 66,000-census emergency department.

15 Oct 2009

Critical Pharmaceuticals to develop hGH nasal spray

Critical Pharmaceuticals, the speciality pharmaceuticals company, today announced that it had secured a £1.5m translation award from the Wellcome Trust to develop a nasal spray of Human Growth Hormone (hGH) using its proprietary CriticalSorb technology as an alternative to injection.

15 Oct 2009

DNA authentication technology to distinguish between in-vivo and in-vitro DNA

Nucleix, Ltd., an emerging life science company specializing in forensic DNA analysis, announced that company researchers today presented its DNA authentication technology, a novel assay to distinguish between in-vivo (real) and in-vitro (fake) DNA, at the 20th International Symposium on Human Identification in Las Vegas, Nevada.

15 Oct 2009

Healthways announces acquisition of behavioral economics company, HealthHonors

Healthways, Inc. today announced the acquisition of HealthHonors, a market-leading behavioral economics company that specializes in behavior change science and optimized use of incentives, in a cash for stock transaction.

15 Oct 2009

Dramatic effects on Norway's health service

If we continue to use our hospitals in the same way as we do now, the health service in 2030 will need to employ every second young person in the country and increase hospital bed capacity by 5000.

15 Oct 2009

Positive data from Cardium Therapeutics' Matrix Phase 2b Excellarate trial

Cardium Therapeutics today reported positive data from its Matrix Phase 2b clinical trial of Excellarate(TM) for the potential treatment of patients with chronic non-healing diabetic foot ulcers based on the Company's Gene Activated Matrix (GAM) technology platform.

15 Oct 2009

Affymetrix unveils Axiom Genotyping Solution

Affymetrix, Inc. (Nasdaq:AFFX) today announced the launch of the Axiom Genotyping Solution, its next-generation array technology designed to match the significant rise in genetic content generated by government and privately funded sequencing projects.

From Beckman Coulter Life Sciences - Automation and Genomics 15 Oct 2009